Vanda Pharmaceuticals Inc. (VNDA) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
7/25
Growth 2
Margin 0
Expansion 4
Platform 0
Financial 1
latest quarter score
Earnings Reports
- 7
- 9
- 8
- 9
- 9
- 11